POLAT-001

DRUG2 trials

Sponsors

Peregrine Ophthalmic

Conditions

GlaucomaLower Eyelid Steatoblepharon

Phase 1

Assess the Safety, Tolerability and Efficacy of Latanoprost Liposome for Lower Eyelid Steatoblepharon

CompletedNCT05935527

Peregrine OphthalmicLower Eyelid Steatoblepharon

Start: 2023-04-28End: 2024-11-18Updated: 2025-01-29

Phase 2

POLAT-001 Compared to Latanoprost Ophthalmic Solution in Patients With Ocular Hypertension and Open-angle Glaucoma

CompletedNCT02466399

Peregrine OphthalmicGlaucoma

Start: 2015-07-31End: 2016-04-30Updated: 2020-11-16